Amarin Corporation PLC ADR (AMRN)

Currency in USD
11.380
-0.290(-2.49%)
Closed·
11.330-0.050(-0.44%)
·
AMRN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.33011.685
52 wk Range
11.25017.310
Key Statistics
Prev. Close
11.67
Open
11.67
Day's Range
11.33-11.685
52 wk Range
11.25-17.31
Volume
36.79K
Average Volume (3m)
74.3K
1-Year Change
-30.355%
Book Value / Share
21.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AMRN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.000
Upside
+14.24%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Amarin Corporation PLC ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Sell

Analysts 12-Month Price Target:

Average 13.000
(+14.24% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Sell13.00+14.24%-New CoverageAug 21, 2026

Amarin Corporation PLC ADR Earnings Call Summary for Q3/2026

  • Amarin returned to profitability with $245K net income in Q3 2026, its first profitable quarter in two years, driven by restructuring efforts.
  • Revenue declined 20.3% to $39.6M as U.S. pricing pressure persisted; management attributed the drop to pricing, not prescription volume weakness.
  • Operating cash flow remained positive for fourth consecutive quarter at $9M; cash position strengthened to $324M, up $21M from year-end 2025.
  • International demand surged 68% YoY in Europe; company expects positive operating cash flow for full-year 2026 with stable U.S. volumes through year-end.
  • Management retained Barclays as financial adviser to review strategic options; warned pricing pressure could continue into 2027 despite near-term stability.
Last Updated: 10/28/2026, 08:42 PM
Read Full Transcript

Earnings

Latest Release
Oct 28, 2026
EPS / Forecast
0.01 / --
Revenue / Forecast
39.55M / 39.14M
EPS Revisions
Last 90 days

AMRN Income Statement

Compare AMRN to Peers and Sector

Metrics to compare
AMRN
Peers
Sector
Relationship
P/E Ratio
−12.5x−1.5x−0.2x
PEG Ratio
−0.160.010.00
Price/Book
0.5x1.7x2.6x
Price / LTM Sales
1.4x2.6x2.8x
Upside (Analyst Target)
14.4%389.4%65.0%
Fair Value Upside
Unlock28.3%9.6%Unlock

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
202.46K0.96%2.30M
Other Institutional Investors
4.26M20.23%48.51M
Public Companies & Retail Investors
16.61M78.81%189.00M
Total
21.07M100.00%239.81M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Sarissa Capital Management LP6.11%1,287,19514,648
Acadian Asset Management LLC3.48%732,9548,341

People Also Watch

22.34
JILL
-0.40%
47.36
PENG
-5.47%
3.370
CLRO
-3.16%
71.60
TEM
-5.65%
8.350
BHC
+1.21%

FAQ

What Is the Amarin ADR (AMRN) Stock Price Today?

The Amarin ADR stock price today is 11.380 USD.

What Stock Exchange Does Amarin ADR Trade On?

Amarin ADR is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Amarin ADR?

The stock symbol for Amarin ADR is "AMRN."

What Is the Amarin ADR Market Cap?

As of today, Amarin ADR market cap is 245.920M USD.

What Is Amarin ADR's Earnings Per Share (TTM)?

The Amarin ADR EPS (TTM) is -0.91.

From a Technical Analysis Perspective, Is AMRN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Amarin ADR Stock Split?

Amarin ADR has split 3 times.

How Many Employees Does Amarin ADR Have?

Amarin ADR has 80 employees.

What is the current trading status of Amarin ADR (AMRN)?

As of Nov 14, 2026, Amarin ADR (AMRN) is trading at a price of 11.380 USD, with a previous close of 11.670 USD. The stock has fluctuated within a day range of 11.330 USD to 11.685 USD, while its 52-week range spans from 11.250 USD to 17.310 USD.

What Is Amarin ADR (AMRN) Price Target According to Analysts?

The average 12-month price target for Amarin ADR is 13.000 USD, with a high estimate of 13 USD and a low estimate of 13 USD. 0 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Sell. The stock has an +14.24% Upside potential.

What Is the AMRN After Hours Price?

AMRN's last after hours stock price is 11.330 USD, the stock has decreased by -0.050, or -0.440%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.